PharmaDocs Episode 5 – 12/23/21
In this episode, the PharmaDocs discuss Lyvispah and Entadfi, two new drugs that have a significant on dental practice. They also discuss management of angina pectoris in the dental office.
In this episode, the PharmaDocs discuss Lyvispah and Entadfi, two new drugs that have a significant on dental practice. They also discuss management of angina pectoris in the dental office.
Drs. Reznick and Roberson discuss two new drugs, Fasenra and Besremi and talk about how these medications can impact management of dental patients. There is also more discussion of pain medication for dental procedures.
In this installment, the PharmaDocs discuss the newly-approved drugs Qulipta and Kerendia and continue their discussion of NSAIDs.
In this episode, Drs. Reznick and Roberson discuss new drugs Opzelura, Wegovy, and Aduhelm and why every practicing dentist should be familiar with them. They also begin a 2-part discussion of NSAIDs.
In the first episode of the PharmaDocs, Drs. Reznick and Roberson discuss the newly-approved drugs Zimhi and Seglentis.
Dr. Rich Mounce discusses oral pathology with an expert panel. May 18, 2021
By Dr. Philip J. Gordon, DDS Feb 15, 2017 | 54 mins
In Part 1 of this 2 part podcast, Dr. Jay Reznick and Dr. John Roberson discuss mental and team preparation for surgery and address the surgical complication of bleeding. APRIL 13, 2021
AUGUST 18, 2020 Dr. Jay Reznick discusses implant complications, peri-implantitis, success and failure in implants, his favored implant systems, CAD/CAM 3D imaging in implant treatment, onlineoralsurgery.com and his advice for young dentists.